KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AmortizationAmortizationAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentChange in Working CapitalChange in Working CapitalDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurora Cannabis (ACB) Asset Writedowns and Impairment (2019 - 2025)

Aurora Cannabis has reported Asset Writedowns and Impairment over the past 7 years, most recently at -$381483.4 for Q3 2025.

  • Quarterly Asset Writedowns and Impairment changed N/A to -$381483.4 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$787369.8 through Dec 2025, down 57.41% year-over-year, with the annual reading at $16.5 million for FY2023, N/A changed from the prior year.
  • Asset Writedowns and Impairment was -$381483.4 for Q3 2025 at Aurora Cannabis, up from -$405886.5 in the prior quarter.
  • Over five years, Asset Writedowns and Impairment peaked at $950.4 million in Q1 2022 and troughed at -$60.4 million in Q3 2022.
  • The 5-year median for Asset Writedowns and Impairment is $411588.7 (2023), against an average of $130.4 million.
  • The largest YoY upside for Asset Writedowns and Impairment was 26548.31% in 2022 against a maximum downside of 1155.44% in 2022.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $35.8 million in 2021, then tumbled by 95.97% to $1.4 million in 2022, then plummeted by 36.49% to $917494.5 in 2023, then plummeted by 144.24% to -$405886.5 in 2024, then grew by 6.01% to -$381483.4 in 2025.
  • Per Business Quant, the three most recent readings for ACB's Asset Writedowns and Impairment are -$381483.4 (Q3 2025), -$405886.5 (Q4 2024), and -$94317.1 (Q2 2024).